Valuation: Celularity Inc.

Market Cap 21.25M 18.45M 17.26M 15.8M 29.78M 2.02B 30.23M 202M 79.28M 1.01B 79.79M 78.06M 3.37B P/E 2024
-0.79x
P/E 2025 -0.31x
Enterprise Value 89.79M 77.93M 72.94M 66.76M 126M 8.54B 128M 854M 335M 4.28B 337M 330M 14.23B EV / Sales 2024
2.12x
EV / Sales 2025 3.77x
Free-Float
62.82%
Yield 2024 *
-
Yield 2025 -
1 day-6.97%
1 week+1.93%
Current month+7.51%
1 month+10.21%
3 months-28.32%
6 months-41.62%
Current year-38.47%
1 week 0.6
Extreme 0.601
0.78
1 month 0.6
Extreme 0.601
0.84
Current year 0.56
Extreme 0.5601
1.51
1 year 0.56
Extreme 0.5601
4.31
3 years 0.56
Extreme 0.5601
7.97
5 years 0.56
Extreme 0.5601
131.86
10 years 0.56
Extreme 0.5601
134
Manager TitleAgeSince
Chief Executive Officer 66 2015-12-31
Director of Finance/CFO 67 2026-02-26
Compliance Officer 42 2021-06-30
Director TitleAgeSince
Chairman 66 2015-12-31
Director/Board Member 64 2017-06-30
Director/Board Member 73 2022-06-02
Date Insider Type Main position Quantity % Market Cap.
1/12/26 Free

Director

19,231 0.0667%
1/12/26 Free

Director

30,000 0.1040%
1/12/26 Free

Director

19,231 0.0667%
Change 5-day change 1-year change 3-year change Capi.($)
-6.97%+1.93%-79.24%-81.14% 21.25M
+0.46%+11.03%+35.48%+0.74% 76.75B
-1.83%-10.32%+20.42%+182.81% 50.46B
+1.54%+2.37%-6.31%+23.71% 48.5B
+1.30%+3.35%-50.46%-50.08% 44.14B
-0.17%-1.41%+55.23%-23.29% 30.53B
-1.19%-6.86%+52.31%+86.04% 24.28B
-4.26%-1.16%+96.07%-50.22% 22.46B
+0.72%+1.39%-7.90%+177.29% 20.04B
+1.13%-5.79%+62.11%+120.47% 16.14B
Average -0.35%+0.55%+17.77%+38.63% 33.33B
Weighted average by Cap. +0.32%+1.06%+21.53%+41.90%

Financials

2024 2025
Net sales 54.22M 47.06M 44.04M 40.31M 75.98M 5.16B 77.13M 515M 202M 2.58B 204M 199M 8.59B 26.55M 23.04M 21.57M 19.74M 37.21M 2.53B 37.77M 252M 99.05M 1.26B 99.68M 97.52M 4.21B
Net income -57.89M -50.25M -47.03M -43.04M -81.13M -5.51B -82.36M -550M -216M -2.76B -217M -213M -9.17B -91.72M -79.61M -74.5M -68.19M -129M -8.72B -130M -872M -342M -4.37B -344M -337M -14.53B
Net Debt 68.1M 59.11M 55.32M 50.63M 95.43M 6.48B 96.87M 647M 254M 3.24B 256M 250M 10.79B 68.54M 59.49M 55.67M 50.96M 96.05M 6.52B 97.5M 652M 256M 3.26B 257M 252M 10.86B
Logo Celularity Inc.
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. Its IMPACT manufacturing platform is a fully integrated process designed to optimize the speed of the sourcing of placentas from full-term healthy informed consent donors through the use of proprietary processing methods, cell selection, product-specific chemistry, manufacturing and control (CMC), advanced cell manufacturing and cryopreservation. It also provides contract manufacturing and development services to third parties.
Employees
115
Date Price Change Volume
26-08-06 US$0.6830 -6.97% 25,289
26-08-05 US$0.7342 +4.38% 10,292
26-08-04 US$0.7034 +6.54% 77,815
26-08-03 US$0.6602 +3.92% 34,469
26-07-31 US$0.6353 -6.57% 80,001

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CELU Stock